Stock MoversStock Movers

Novo Nordisk's Ozempic Pill Fails to Slow Alzheimer's, Amazon Rises, Tesla Jumps

View descriptionShare

On this episode of Stock Movers:

- Novo Nordisk (NVO) dropped after a pill version of Ozempic failed to slow the progression of Alzheimer’s disease in a pair of long-shot studies that aimed to open up a new use for blockbuster obesity drugs.

- Amazon (AMZN) is rising. The company says it will spend as much as $50 billion, expanding its capacity to provide artificial intelligence and high-performance computing services to US government entities.

- Tesla (TSLA) shares jumped around 7% on Monday after a Sunday post on X from Elon Musk commenting on the company’s AI chip plans.

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Stock Movers

    1,426 clip(s)

Stock Movers

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subs 
Social links
Follow podcast
Recent clips
Browse 1,427 clip(s)